Close Menu

NEW YORK, June 27 - Syrrx and Cubist Pharmaceuticals have entered a deal to jointly develop potential antibiotic drugs, the companies said Tuesday.  

The deal represents the first collaboration with a pharmaceutical company for San Diego, Calif.-based Syrrx. The company currently has several other relationships to develop its technology platform for determining protein structures.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Wired reports that researchers have shown they could reprogram a DNA-based computer.

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

In Science this week: whole-genome sequencing of single sperm cells, and more.